Regular checks of serum AFP levels in patients who originally had high AFP levels to recognize HCC recurrence is suggested as a practice guideline by the National Comprehensive Cancer Network (NCCN) version 1, 2009. This evidence concerns the gene AFP and hepatocellular carcinoma.